Cargando…
Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products
The receptor for advanced glycation end-products (RAGE) is implicated in multiple disease states such as cancer, diabetes and neurodegenerative disorders, and RAGE inhibitors are being explored as potential new therapies in such cases. Despite the known role RAGE plays in these conditions, there rem...
Autores principales: | Drake, Lindsey R., Scott, Peter J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299691/ https://www.ncbi.nlm.nih.gov/pubmed/30613302 http://dx.doi.org/10.7150/thno.31515 |
Ejemplares similares
-
Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles
por: Konopka, Christian J., et al.
Publicado: (2018) -
Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011) -
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020) -
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010) -
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021)